Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 8, 2000, Pages 1903-1911

  Bayraktutan, Ulvi ^a   Blayney, Lynda ^b   Shah, Ajay M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

cDNA; Endothelium; NADPH oxidase; Reactive oxygen species

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME SPECIFICITY; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GLYCOSYLATION; MALE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0033897196     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.8.1903     Document Type: Article

References (55)

1. Cellular and molecular mechanisms of endothelial cell dysfunction
2. Atherosclerosis: An inflammatory disease
3. Hypercholesterolemia increases endothelial superoxide anion production
4. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
5. Cyclic-strain-induced plasminogen activator inhibitor-1 (PAI-1) release from endothelial cells involves reactive oxygen species
6. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells
7. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1
8. Modulation of Ras/Raf/extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response-1 gene expression in endothelial cells
9. Oxygen-derived free radicals in post-ischemic injury
10. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium
11. Expression of phagocyte NADPH oxidase components in human endothelial cells
12. Expression of a functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells
13. Effect of NADPH oxidase inhibition on endothelial cell ELAM-I mRNA expression
14. Chronic granulomatous disease
15. Interactions between the components of the human NADPH oxidase: Intrigues in the phox family
16. Assembly of the phagocyte NADPH oxidase: Molecular interaction of oxidase proteins
17. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
18. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation
19. p22(phox) is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
20. 2 sensor
21. Cell transformation by the superoxide-generating oxidase Mox1
22. Microvascular endothelial cells from heart
23. Cytochrome b-558 α-subunit cloning and expression in rat aortic smooth muscle cells
24. Interleukin-4 suppresses the expression of macrophage NADPH oxidase heavy chain subunit (gp91 phox)
25. TaqStart antibody: Hotstart PCR facilitated by a neutralising monoclonal antibody directed against Taq DNA polymerase
26. Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: Thermal RACE
27. Touchdown PCR to circumvent spurious priming during gene amplification
28. Match-Box-server: A multiple sequence alignment tool placing emphasis on reliability
29. Characterisation of two monoclonal antibodies against cytochrome b558 of human neutrophils
30. Immunoelectron microscopy shows a clustered distribution of NADPH oxidase components in the human neutrophil plasma membrane
31. Association of Ras-related protein with cytochrome b of human neutrophils
32. Identification of phospholipase C β isoforms and their location in cultured vascular smooth muscle cells of pig, human and rat
33. 2)-vitamin D3 in monocytic U937 cells
34. Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b
35. Complementary DNA for the mouse homolog of the small subunit of human cyb558
36. Cloning and expression of the gene encoding porcine NADPH oxidase light-chain subunit
37. Cloning and sequencing of the bovine flavocytochrome b subunit protects, gp91-phox and p22-phox: Comparison with other known flavocytochrome b sequences
38. The X-linked CGD gene codes for the β-chain of cyb245
39. Cloning of murine gp91 phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line
40. Analysis of glycosylation sites on gp91 phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro
41. The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct
42. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II
43. Functional expression of NADPH oxidase components (α- and β-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells
44. 2 sensor protein in the rat carotid body
45. Measurement and characterisation of superoxide generation in microglial cells: Evidence for an NADPH oxidase-dependent pathway
46. NADPH oxidase of chondrocytes contains an isoform of the gp91 phox subunit
47. + channel
48. 558 of the human NADPH oxidase
49. -245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes
50. Assisted protein folding
51. Ultrastructural localisation of cytochrome b in the membranes of resting and phagocytosing human granulocytes
52. 558: Role of heme incorporation and heterodimer formation in maturation and stability of gp91(phox) and p22(phox) subunits
53. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients
54. 558